Exploring Autophagy-related Prognostic Genes of Alzheimer's Disease Based on Pathway Crosstalk Analysis

Overview

Journal Bosn J Basic Med Sci

Specialty General Medicine

Date 2022 Apr 2

PMID 35366391

Authors

Fang Qian

Wei Kong

Shuaiqun Wang

Affiliations

Soon will be listed here.

Abstract

Recent studies have shown that different signaling pathways are involved in the pathogenesis of Alzheimer's disease (AD), with complex molecular connections existing between these pathways. Autophagy is crucial for the degradation and production of pathogenic proteins in AD, and it shows link with other AD-related pathways. However, current methods for identifying potential therapeutic targets for AD are primarily based on single-gene analysis or a single signal pathway, both of which are somewhat limited. Finding other methods is necessary for providing novel underlying AD therapeutic targets. Therefore, given the central role of autophagy in AD and its interplay with its pathways, we aimed to identify prognostic genes related to autophagy within and between these pathways based on pathway crosstalk analysis. The method of pathway analysis based on global influence (PAGI) was applied to find the feature mRNAs involved in the crosstalk between autophagy and other AD-related pathways. Subsequently, the weighted gene co-expression network analysis (WGCNA) was used to construct a co-expression module of feature mRNAs and differential lncRNAs. Finally, based on 2 autophagy-related crosstalk genes (CD40 and SMAD7), we constructed a prognosis model by multivariate Cox regression, which could predict the overall survival of AD patients with medium-to-high accuracy. In conclusion, we provided an effective method for extracting autophagy-related significant genes based on pathway crosstalk in AD. We found the biomarkers valuable to the AD prognosis, which may also play an essential role in the development and treatment of AD.

Citing Articles

MicroRNAs regulating autophagy: opportunities in treating neurodegenerative diseases.

Mohseni M, Behzad G, Farhadi A, Behroozi J, Mohseni H, Valipour B Front Neurosci. 2024; 18:1397106.

PMID: 39582602 PMC: 11582054. DOI: 10.3389/fnins.2024.1397106.

Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer's Disease Cohorts.

Wang H, Li J, Tu W, Wang Z, Zhang Y, Chang L J Alzheimers Dis. 2024; 100(4):1261-1287.

PMID: 39093073 PMC: 11380308. DOI: 10.3233/JAD-240301.

Biomarker Genes Discovery of Alzheimer's Disease by Multi-Omics-Based Gene Regulatory Network Construction of Microglia.

Gao W, Kong W, Wang S, Wen G, Yu Y Brain Sci. 2022; 12(9).

PMID: 36138932 PMC: 9496783. DOI: 10.3390/brainsci12091196.

References

Kirouac L, Rajic A, Cribbs D, Padmanabhan J . Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease. eNeuro. 2017; 4(2). PMC: 5367084. DOI: 10.1523/ENEURO.0149-16.2017. View

Ho G, Drego R, Hakimian E, Masliah E . Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy. 2005; 4(2):247-56. DOI: 10.2174/1568010053586237. View

Salins P, He Y, Olson K, Glazner G, Kashour T, Amara F . TGF-beta1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis. Neurosci Lett. 2007; 430(1):81-6. DOI: 10.1016/j.neulet.2007.10.025. View

Mitre M, Mariga A, Chao M . Neurotrophin signalling: novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 2016; 131(1):13-23. PMC: 5295469. DOI: 10.1042/CS20160044. View

Han J, Li C, Yang H, Xu Y, Zhang C, Ma J . A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways. J R Soc Interface. 2015; 12(102):20140937. PMC: 4277084. DOI: 10.1098/rsif.2014.0937. View

Akhtar A, Sah S . Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease. Neurochem Int. 2020; 135:104707. DOI: 10.1016/j.neuint.2020.104707. View

Tan J, Town T, Suo Z, Wu Y, Song S, Kundtz A . Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides. Brain Res Bull. 1999; 50(2):143-8. DOI: 10.1016/s0361-9230(99)00122-7. View

Zhang J, Suo Y, Liu M, Xu X . Identification of genes related to proliferative diabetic retinopathy through RWR algorithm based on protein-protein interaction network. Biochim Biophys Acta Mol Basis Dis. 2017; 1864(6 Pt B):2369-2375. DOI: 10.1016/j.bbadis.2017.11.017. View

Wang L, Li J, Zhao H, Hu J, Ping Y, Li F . Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes. Mol Biosyst. 2016; 12(3):711-20. DOI: 10.1039/c5mb00700c. View

10.

Li C, Li X, Miao Y, Wang Q, Jiang W, Xu C . SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Res. 2009; 37(19):e131. PMC: 2770656. DOI: 10.1093/nar/gkp667. View

11.

Niemira M, Collin F, Szalkowska A, Bielska A, Chwialkowska K, Reszec J . Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA). Cancers (Basel). 2019; 12(1). PMC: 7017323. DOI: 10.3390/cancers12010037. View

12.

Li C, Han J, Yao Q, Zou C, Xu Y, Zhang C . Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Res. 2013; 41(9):e101. PMC: 3643575. DOI: 10.1093/nar/gkt161. View

13.

Palfy M, Remenyi A, Korcsmaros T . Endosomal crosstalk: meeting points for signaling pathways. Trends Cell Biol. 2012; 22(9):447-56. PMC: 3430897. DOI: 10.1016/j.tcb.2012.06.004. View

14.

Colacurcio D, Pensalfini A, Jiang Y, Nixon R . Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease. Free Radic Biol Med. 2017; 114:40-51. PMC: 5748263. DOI: 10.1016/j.freeradbiomed.2017.10.001. View

15.

Gabbouj S, Ryhanen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S . Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway. Front Neurosci. 2019; 13:629. PMC: 6591470. DOI: 10.3389/fnins.2019.00629. View

16.

Uddin M, Al Mamun A, Labu Z, Hidalgo-Lanussa O, Barreto G, Ashraf G . Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis. J Cell Physiol. 2018; 234(6):8094-8112. DOI: 10.1002/jcp.27588. View

17.

Lee S, Salazar S, Cox T, Strittmatter S . Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss. J Neurosci. 2019; 39(10):1910-1929. PMC: 6407289. DOI: 10.1523/JNEUROSCI.2983-18.2018. View

18.

Zenaro E, Piacentino G, Constantin G . The blood-brain barrier in Alzheimer's disease. Neurobiol Dis. 2016; 107:41-56. PMC: 5600438. DOI: 10.1016/j.nbd.2016.07.007. View

19.

Li Z, Xiao Y, Xu L, Wang Q . Mining the key genes for ventilator-induced lung injury using co-expression network analysis. Biosci Rep. 2021; 41(3). PMC: 7969703. DOI: 10.1042/BSR20203235. View

20.

Xu X, Cui L, Zhong W, Cai Y . Autophagy-Associated lncRNAs: Promising Targets for Neurological Disease Diagnosis and Therapy. Neural Plast. 2020; 2020:8881687. PMC: 7528122. DOI: 10.1155/2020/8881687. View